BRKR 8-K
Bruker Corp (BRKR)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
|
|||
(State or other jurisdiction of |
|
Commission File No. |
|
(I.R.S. Employer |
Incorporation or organization) |
|
|
|
Identification No.) |
(Address of principal executive offices) (Zip Code)
(
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
|
Trading Symbol(s) |
|
Name of Each Exchange on Which Registered |
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Section 5 - Corporate Governance and Management
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
Bruker Corporation 2026 Incentive Compensation Plan
At the 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) of Bruker Corporation (the “Company”), held on May 29, 2025, the Company’s stockholders approved the Bruker Corporation 2026 Incentive Compensation Plan (the “2026 Plan”), which was approved by the Company’s Board of Directors (the “Board”) on February 18, 2025, subject to stockholder approval. The 2026 Plan will be effective as of February 19, 2026 (the “Effective Date”), which will be the date immediately following the date on which the Bruker Corporation 2016 Incentive Compensation Plan (the “Prior Plan”) expires. Subject to adjustment as set forth in the 2026 Plan, the aggregate number of shares of common stock, $0.01 par value (the “Common Stock”) authorized for issuance or delivery pursuant to the 2026 Plan will not exceed 12,000,000 shares of Common Stock, which is comprised of:
In addition, shares of the Common Stock underlying any outstanding award granted under the Prior Plan or the 2026 Plan that, following the Effective Date, expires, or is terminated, cancelled, exchanged, surrendered or forfeited for any reason without issuance of such shares will again be available for awards under the 2026 Plan. The 2026 Plan replaces the Prior Plan, and no additional awards will be granted under the Prior Plan on or after the Effective Date.
The 2026 Plan, which will be administered by the Compensation Committee of the Board or another committee appointed by the Board to administer the 2026 Plan (the “Committee”), provides for grants of awards to non-employee directors, employees, and certain key advisors of the Company and its subsidiaries in the form of nonqualified and incentive options, stock awards, stock units, stock appreciation rights, cash-based awards, and other awards. It is not possible to determine specific amounts and types of awards that may be granted to eligible participants under the 2026 Plan because the grant and payment of such awards is subject to the discretion of the Committee. The 2026 Plan will terminate on May 28, 2035, unless terminated earlier pursuant to its terms.
The foregoing description of the 2026 Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the 2026 Plan, a copy of which is filed herewith as Exhibit 10.1 and incorporated herein by reference.
Item 5.07. Submission of Matters to a Vote of Security Holders.
The proposals submitted by the Board to a vote of the stockholders at the 2025 Annual Meeting, and the results of the voting on each proposal, are indicated below. Each proposal is described in greater detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 11, 2025.
Proposal No. 1 – Election of Directors
The following director nominees were elected to serve as Class I members of the Company’s board of directors, each to serve for a three-year term until the Company’s 2028 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified based on the following votes:
Nominees for Class I director: |
|
For |
|
Withheld |
|
Broker Non-Votes |
Bonnie H. Anderson |
|
101,286,113 |
|
26,776,506 |
|
17,338,019 |
Frank H. Laukien, Ph.D. |
|
114,517,162 |
|
13,545,457 |
|
17,338,019 |
John A. Ornell |
|
116,785,189 |
|
11,277,430 |
|
17,338,019 |
Richard A. Packer |
|
89,464,768 |
|
38,597,851 |
|
17,338,019 |
Proposal No. 2 – Advisory Vote on the 2024 Compensation of Named Executive Officers
The proposal to approve, on an advisory basis, the 2024 compensation of the named executive officers as disclosed in the Company’s proxy statement for the 2025 Annual Meeting was approved based on the following votes:
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
108,807,969 |
|
6,023,904 |
|
37,973 |
|
17,338,019 |
Proposal No. 3 – Ratification of the Appointment of Independent Registered Public Accounting Firm
The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2025 was approved based on the following votes:
For |
|
Against |
|
Abstain |
131,634,268 |
|
540,708 |
|
32,889 |
Proposal No. 4 – Adoption of the Bruker Corporation 2026 Incentive Compensation Plan
The proposal to approve the adoption of the Bruker Corporation 2026 Incentive Compensation Plan was approved based on the following votes:
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
90,071,055 |
|
24,751,839 |
|
46,952 |
|
17,338,019 |
Section 9 – Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) |
Exhibits. |
||
|
|
|
|
|
Number |
|
Description |
|
|
|
|
|
10.1 |
|
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BRUKER CORPORATION |
|
|
|
|
Date: May 29, 2025 |
By: |
/s/ GERALD N. HERMAN |
|
|
Gerald N. Herman |
|
|
Executive Vice President and Chief Financial Officer |
EXHIBIT 10.1
BRUKER CORPORATION
2026 INCENTIVE COMPENSATION PLAN
Effective as of the Effective Date, the Bruker Corporation 2026 Incentive Compensation Plan (as may be amended from time to time, the “Plan”) is hereby established.
The purpose of the Plan is to provide employees of Bruker Corporation, a Delaware corporation (together with its successors, the “Company”), and its subsidiaries, certain consultants and advisors who perform services for the Company or its subsidiaries, and non-employee members of the Board, with the opportunity to receive grants of equity awards in the form of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units, and other stock-based awards or cash-based awards. Capitalized terms used in the Plan and not otherwise defined herein shall have the meaning assigned to them in Section 2.
The Company believes that the Plan will encourage the Participants to contribute materially to the growth of the Company, thereby benefiting the Company’s stockholders, and will align the economic interests of the Participants with those of the stockholders.
The Plan is intended to replace the Prior Plan. No additional grants shall be made under the Prior Plan on or after the Effective Date. Outstanding grants under the Prior Plan shall continue in effect according to their terms.
The following terms shall have the meanings set forth below:
1
The Committee may modify the definition of Change in Control for a particular Award as the Committee deems appropriate to comply with Section 409A of the Code or otherwise. Notwithstanding the foregoing, if an Award constitutes deferred compensation subject to Section 409A of the Code and the Award provides for payment upon a Change in Control, then, for purposes of such payment provisions, no Change in Control shall be deemed to have occurred upon an event described in items (i) – (iv) above unless the event would also constitute a change in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under Section 409A of the Code.
2
3
4
5
The Committee may grant Options to an Employee, Non-Employee Director or Key Advisor upon such terms as the Committee deems appropriate. The following provisions are applicable to Options:
6
The Committee may issue or transfer shares of Company Stock to an Employee, Non‑Employee Director or Key Advisor under a Stock Award, upon such terms as the Committee deems appropriate. The following provisions are applicable to Stock Awards:
7
The Committee may grant Stock Units, each of which shall represent one hypothetical share of Company Stock, to an Employee, Non-Employee Director or Key Advisor upon such terms and conditions as the Committee deems appropriate. The following provisions are applicable to Stock Units:
The Committee may grant SARs to an Employee, Non‑Employee Director or Key Advisor separately or in tandem with any Option. The following provisions are applicable to SARs:
8
The Committee may grant Cash-Based Awards, which are awards denominated in cash rather than shares of Company Stock and payable in cash, to any Employee, Non-Employee Director or Key Advisor, on such terms and conditions as the Committee shall determine. The Committee may grant Other Stock-Based Awards, which are awards (other than those described in Sections 7, 8, 9 and 10 of the Plan) that are based on or measured by Company Stock and may be payable in cash, Company Stock or any combination of the foregoing, to any Employee, Non-Employee Director or Key Advisor, on such terms and conditions as the Committee shall determine. Subject to Section 4(b), Cash-Based Awards and Other Stock-Based Awards may be awarded subject to the achievement of Performance Goals or other criteria or other conditions, as the Committee shall determine.
The Committee may grant Dividend Equivalents in connection with Stock Units or Other Stock-Based Awards in an applicable Award Agreement or at any point following the grant of such Award. Dividend Equivalents may be paid currently or accrued as contingent cash obligations and may be payable in cash or shares of Company Stock, and upon such terms and conditions as the Committee shall determine. For the avoidance of doubt, dividends or Dividend Equivalents shall not be granted in connection with Options or SARs.
9
The Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise be due to such Participant in connection with any Award. If any such deferral election is permitted or required, the Committee shall establish rules and procedures for such deferrals and may provide for interest or other earnings to be paid on such deferrals. The rules and procedures for any such deferrals shall be consistent with applicable requirements of Section 409A of the Code.
No Company Stock shall be issued or transferred in connection with any Award hereunder unless and until all legal requirements applicable to the issuance or transfer of such Company Stock have been complied with to the satisfaction of the
10
Committee. The Committee shall have the right to condition any Award made to any Participant hereunder on such Participant’s undertaking in writing to comply with such restrictions on the Participant’s subsequent disposition of such shares of Company Stock as the Committee shall deem necessary or advisable, and certificates, or electronic book entry equivalents, representing such shares may be legended to reflect any such restrictions. Certificates, or electronic book entry equivalents, representing shares of Company Stock issued under the Plan may be subject to such stop-transfer orders and other restrictions as may be required by applicable laws, regulations and interpretations, including any requirement that a legend be placed thereon. No Participant shall have any right as a stockholder with respect to Company Stock covered by an Award until shares have been issued to the Participant.
11
12
***
13